CVS's Karen Lynch Was Just Ousted. Why Women CEOs Are 45% More Likely to Get Fired Than Men.
Correction to Saturday Heard on the Street Article About Health Insurers -- WSJ
Kenvue Stock Jumps on a Report That Activist Starboard Is Getting Involved -- Barrons.com
Unusual Options Activity: WFC, SNAP and Others Attract Market Bets, WFC V/OI Ratio Reaches 156.8
EST Oct 21st Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
CVS Health Preannounces Large Earnings Miss, But Analysts Stay Bullish On Long-Term Recovery
Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms
Why Did CVS Health Plunge?
Morgan Stanley Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $63
Watch Netflix, CVS Health, Cigna and More
Strategic Leadership Change and Financial Realignment: Reasons Behind CVS Health's Buy Rating
Evercore Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $75
Can cvs health (CVS.US) resolve the 'An Tai crisis' with an urgent change of leadership? This is how Wall Street looks at it.
Can the new CEO of CVS Health handle the challenges from Anthem?
Truist Financial Maintains CVS Health(CVS.US) With Buy Rating
Analysts Are Neutral on These Healthcare Stocks: CVS Health (CVS), Vertex Pharmaceuticals (VRTX)
Strategic Turnaround and Leadership Shift Position CVS Health for Long-term Growth
Express News | CVS Health Corp : Morgan Stanley Cuts Target Price to $63 From $65
US stocks gold rush | Performance and stock prices soar! Netflix, robotic surgery leader ISRG hit record highs; Gold price breaks through $2700! Kinross Gold and other multiple golden industrial concepts collectively celebrate.
Bitcoin approaches $70,000! Bitcoin whale MSTR soared 11% last Friday, making up for the previous 4 days of decline, with the stock price back above the $200 mark.
Barclays Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $82
CVS Health (CVS) Gets a Buy From Barclays
Are CVS Health Corporation's (NYSE:CVS) Mixed Financials Driving The Negative Sentiment?